The prospect that a simple blood test - a liquid biopsy - can reveal information about a patient’s cancer has led healthcare practitioners to feel both excitement and skepticism about the future. Dr. John Leonard discusses the potential value and limitations of using these blood tests to assess circulating tumor DNA (ctDNA) in people with lymphoma.
6 сен 2024
